Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
How Are Anti-VEGF Therapies Shaping the Choroidal Neovascularization Market?
Anti-VEGF therapies are the cornerstone of the choroidal neovascularization market. Drugs that inhibit vascular endothelial growth factor reduce abnormal blood vessel growth and leakage, preserving vision in patients with CNV. Since their introduction, these therapies have transformed treatment and expanded the market. In the choroidal neovascularization market, competition among anti-VEGF...
0 Comments ·0 Shares ·124 Views ·0 Reviews
Please log in to like, share and comment!